Biocheck, Inc.

Biocheck, Inc. — FDA 510(k) Submissions

Biocheck, Inc. has submitted 14 FDA 510(k) premarket notifications since 1999, of which 14 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Radioimmunoassay, Thyroid-stimulating Hormone, Immunoassay Method, Troponin Subunit, Amplifier And Signal Conditioner, Biopotential, System, Test, C-reactive Protein, Radioimmunoassay, Total Triiodothyronine . Use the specialty filter in the sidebar to narrow results.